Evidence map›Paper›PMID 32767992›Full record

ArticleBMC pediatrics2020

Colostrum oropharyngeal immunotherapy for very low birth weight preterm infants: protocol of an intervention study.

Camilla da Cruz Martins, Michelle de Santana Xavier Ramos, Mara Viana Cardoso Amaral, Jéssica Santos Passos Costa, Ellayne Souza Cerqueira, Tatiana de Oliveira Vieira, Simone Seixas dA Cruz, Graciete Oliveira Vieira

Open access · goldAbstract readClinical Trial Protocol
In one paragraph

Article in BMC pediatrics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.9field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 26 citations in OpenAlex.

  1. Trial
  2. Observational
  3. Observational
  4. Construction and validation of nursing diagnoses for premature newborns.Revista da Escola de Enfermagem da U S P · 2023
    Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Camilla da Cruz MartinsState University of Feira de Santana, Av. Transnordestina, s/n - Novo Horizonte, CEP: 44036-900, Feira de Santana, Bahia, Brazil. martinsmilla@hotmail.com.ORCID 0000-0002-6946-4618
Michelle de Santana Xavier RamosFederal University of Recôncavo da Bahia, Santo Antônio de Jesus, Bahia, Brazil.
Mara Viana Cardoso AmaralState University of Feira de Santana, Av. Transnordestina, s/n - Novo Horizonte, CEP: 44036-900, Feira de Santana, Bahia, Brazil.
Jéssica Santos Passos CostaState University of Feira de Santana, Av. Transnordestina, s/n - Novo Horizonte, CEP: 44036-900, Feira de Santana, Bahia, Brazil.
Ellayne Souza CerqueiraFederal University of Bahia, Salvador, Bahia, Brazil.
Tatiana de Oliveira VieiraState University of Feira de Santana, Av. Transnordestina, s/n - Novo Horizonte, CEP: 44036-900, Feira de Santana, Bahia, Brazil.
Simone Seixas dA CruzFederal University of Recôncavo da Bahia, Santo Antônio de Jesus, Bahia, Brazil.
Graciete Oliveira VieiraState University of Feira de Santana, Av. Transnordestina, s/n - Novo Horizonte, CEP: 44036-900, Feira de Santana, Bahia, Brazil.
Universidade Estadual de Feira de Santana · BRUniversidade Federal do Recôncavo da Bahia · BRUniversidade Federal da Bahia · BR

Funding

FAPESB 4996/2017
6 · The paper itself

Abstract

backgroundThe oropharyngeal colostrum administration protocol to treat premature newborns is a possible and plausible strategy in neonatal health services, since the immunoprotective components of colostrum can be absorbed by the lymphoid tissues of the oropharynx. In this context, this study aims to describe the implementation of oropharyngeal colostrum immunotherapy in very low birth weight preterm newborns in a neonatal unit, as well as to test an algorithm in a public hospital.

methodsThe protocol is applied in a non-randomized, superiority clinical trial with historical control. In the treatment group, 0.2 mL of raw colostrum is dripped into the right and left oropharyngeal mucosa, totaling 8 administrations every 24 h until the 7th complete day of life interruptedly. The control group consists of very low birth weight preterm newborns born in the same hospital in previous years (historical control). The clinical progression of 60 newborns until hospital discharge is recorded on standardized forms. A total of 350 participants are estimated to complete the survey in 4 years. The occurrence of continuous outcomes between the groups are compared through the paired t-test or Wilcoxon's two-sample test. The chi-square test or Fisher's exact test, and survival analysis are used for binary outcomes. The nutritional status is assessed through Intergrowth-21st growth curves for preterm newborns. DISCUSSION: The flows of the protocol's actions is sorted by an algorithm, compatible with the Brazilian reality of a public hospital. This measure facilitates and systematizes clinical care, organizes the team's work process, speeds up the intervention steps, standardizes decision-making and unifies the quality of care, besides showing the feasibility of oropharyngeal colostrum immunotherapy.

trial registrationReBEC, U1111-1222-0598 , Registered 09 October 2018, http://www.ensaiosclinicos.gov.br/rg/RBR-2cyp7c/ .

Indexed as

ColostrumInfant, PrematureBirth WeightClinical Trials as TopicFemaleHumansImmunotherapyInfantInfant, NewbornInfant, Very Low Birth WeightOropharynxPregnancyClinical trial protocolColostrumHumansImmunotherapyPreterm newborn

Identifiers

PMID32767992
PMCPMC7411269
OpenAlexW3047770263

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.